White House: Eli Lilly’s insulin price cap shows why GOP should stop attacking the Inflation Reduction Act
EXCLUSIVE: The White House said Wednesday that pharmaceutical giant Eli Lilly’s move to cap out-of-pocket costs for insulin at $35 for patients